Paul Koppang signed Nephron Pharmaceuticals Corp.'s 2024 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Nephron Pharmaceuticals Corp.'s EIN is 93-1065757.
Download the official 2024 Form 5500 (PDF) for Nephron Pharmaceuticals Corp. from the U.S. Department of Labor's EFAST2 system.
Download the official 2024 Form 5500 (PDF)Nephron Pharmaceuticals Corp.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).
Holdings are itemized directly on this plan's Schedule of Assets, below.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| EMPOWER ANNUITY INSURANCE COMPANY O | — | GREENWOOD VILLAGE, CO | RECORDKEEPER | $139K | — |
| EMPOWER ADVISORY GROUP, LLC | — | GREENWOOD VILLAGE, CO | INVESTMENT MGMT | $792 | — |
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|
Detected from the parsed Schedule of Assets. Click a family to see every plan that holds it — ranked by position size.
| CREATIVE PLANNING HOLDCO LLC | — | OVERLAND PARK, KS | INVESTMENT ADVISOR | $27K | — |
| MORGAN STANLEY | — | NEW YORK, NY | INVESTMENT ADVISOR | $4K | — |
| MORGAN STANLEY SMITH BARNEY LLC | — | NEW YORK, NY | INVESTMENT ADVISOR | $671 | — |
